Zenas BioPharma CEO Lonnie Moulder bought $1.64M in ZBIO stock after a 52% crash. His track record: $10B+ in biotech exits including TESARO sold to GSK.

Zenas BioPharma CEO Bets $1.64M on Stock After 52% Crash—His Track Record: $10 Billion in Exits

Zenas BioPharma CEO bought $1.64M in stock over 3 days after positive Phase 3 data crashed shares 52%. Stock now up 40% from lows.

Zenas BioPharma CEO Buys $1.64M in Stock Days After Phase 3 Win Triggered 52% Crash

Zenas BioPharma CEO Lonnie Moulder buys $1.63M in ZBIO stock after 52% crash. Serial biotech founder with $9B in exits bets on his own company.

Leadership at Zenas BioPharma

Executives at Zenas BioPharma

Leon O. Moulder, Jr.

Haley Laken

Jennifer Fox

Joseph Farmer

Lisa von Moltke

Orlando Oliveira

Board Members at Zenas BioPharma

Hongbo Lu, Ph.D.

Jake Nunn

James Boylan

John Orloff, M.D.

Patricia Allen

Patrick Enright

Tomas Kiselak

Recent News about Zenas BioPharma

Zenas BioPharma CEO Bets $1.64M on Stock After 52% Crash—His Track Record: $10 Billion in Exits

Zenas BioPharma CEO Buys $1.64M in Stock Days After Phase 3 Win Triggered 52% Crash

Zenas BioPharma CEO Buys $1.6M in Stock After 52% Crash